Deal Watch: Lundbeck Acquires Chelsea As Industry Awaits Possible AstraZeneca, Allergan Buyouts
Executive Summary
Merck sells off its consumer business to Bayer AG in a deal in which the two companies also will co-develop and co-commercialize sGC modulator drugs. Lundbeck buys out Chelsea and its recently approved dizziness drug Northera.
You may also be interested in...
Danish Lundbeck’s Brexpiprazole Could Reach U.S. Market In 2015
But the CNS disease specialist also expects the continuing loss of marketing exclusivity on key products and product launch costs to hold back revenue growth and profits in 2015 that will not be fully compensated by sales from multiple new product launches around the world.
Bigger And Smaller? Pfizer Pursues AstraZeneca But Hasn’t Given Up On A Split
A Pfizer break up is still an option even if the company completes a mega-merger with AstraZeneca, CEO Ian Read said May 5. The company’s first quarter sales and earnings results highlighted how important completing a transaction could be for the company, with sales down 9% and earnings down 15%.
Amgen Enters Cancer Biologics Deal With Oxford Genome Sciences
Collaboration is the second in recent months to involve Amgen’s XenoMouse human monoclonal antibody generating technology.